Access cutting-edge neuroendocrine carcinoma treatment through this clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Berkeley location
Access neuroendocrine carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuroendocrine carcinoma treatment provided free
Check if you qualify for this neuroendocrine carcinoma clinical trial in Berkeley, CA
No-Cost Study Care
Local to Berkeley
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary s
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT05058651) has an active research site in Berkeley, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neuroendocrine carcinoma treatment options in Berkeley, CA, this clinical trial (NCT05058651) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroendocrine carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neuroendocrine carcinoma clinical trials near you to find additional studies recruiting in your area.
See all neuroendocrine tumors clinical trials recruiting in Berkeley — not just this study.
Browse Neuroendocrine Tumors Trials in Berkeley →